Dow Up 0.07% Nasdaq Up 0.61%

Enanta Pharmaceuticals, Inc. (ENTA)

-NasdaqGS
47.99 Up 2.64(5.82%) Nov 26, 4:00PM EST
Prev Close:45.35
Open:45.60
Bid:47.56 x 100
Ask:N/A
1y Target Est:45.00
Beta:0.543
Earnings Date:Feb 16 - Feb 20 (Est.)
Day's Range:45.51 - 48.00
52wk Range:26.90 - 48.49
Volume:438,377
Avg Vol (3m):309,858
Market Cap:892.09M
P/E (ttm):26.66
EPS (ttm):1.80
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ENTA

Comparison

Symbol% ChgMkt Cap
ENTAUp 5.82%892.09M
IDIX 0.00%N/A
MRKUp 0.69%170.34B
VRTXUp 1.05%27.75B

Key Statistics

Forward P/E (1 yr):11.82
P/S (ttm):17.66
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-15) :8.55
Quarterly EPS Est (Dec-14) :3.53
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Enanta Pharmaceuticals, Inc., a biotechnology company, is engaged in the development of small molecule drugs for the infectious disease field. Its product portfolio includes ABT-450, a protease inhibitor that is in Phase III clinical trials for th... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback